Covid-19 Vaccine Maker Sinovac See Earnings Plunge in H1 2022

ich once rose due to the pandemic, has fallen to a record low in more than three years since the end of May 2021. As of the close of trading on Tuesday, Sinovac Biotech was quoted at $0.53 per share, a cumulative decline of over 50% from its highest closing price in 2021, and a cumulative decline of 23.99% in 2022.

更多精彩内容，注目钛媒体腾讯号（ID：taimeiti），或者下载钛媒体App

。

关节僵硬了吃什么药
南京肛肠医院哪家专业
武威哪个医院看白癜风比较好
江苏妇科检查哪家医院好
云南男科专科医院有哪些